SCHEMBL24334609

SCHEMBL24334609

CC(C)n1ncc2c(C(=O)Nc3ccccn3)cc(-c3cccs3)nc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.53
ALDH1A1 P00352 6/20 0.53
MAPT P10636 5/20 0.53
GAA P10253 2/20 0.53
POLB P06746 2/20 0.53
MAT2A P31153 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 4/20 0.45
HTT P42858 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
TP53 P04637 1/20 0.43
KDM5B Q9UGL1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29944917 1.00 KDM4E (0.53) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL23633375 0.90 MAT2A (0.49) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL16783126 0.85 RXFP1 (0.55) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL16783112 0.84 RXFP1 (0.48) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL20869963 0.84 KDM4E (0.52) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL23633374 0.83 OPRM1 (0.48) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL23633377 0.83 TP53 (0.50) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL16783111 0.81 L3MBTL1 (0.49) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL16783143 0.80 RXFP1 (0.47) KDM4EALDH1A1MAPTGAAPOLB
SCHEMBL16783120 0.80 RXFP1 (0.54) KDM4EALDH1A1MAPTGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787799-B2 Potent antiviral pyrazolopyridine compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-17 US disclosed
US-11787799-B2 Potent antiviral pyrazolopyridine compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-17 US disclosed
US-20220119384-A1 POTENT ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787799-B2 Potent antiviral pyrazolopyridine compounds MAVS, VRK1, VRK2 KDM4E 3301/4885ALDH1A1 2083/4885MAPT 4023/4885
US-20220119384-A1 POTENT ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS MAVS, VRK1, VRK2 KDM4E 3301/4885ALDH1A1 2083/4885MAPT 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.